SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

TAVR in Small Annuli: What Valve Should We Use?

Dr. Carlos Fava - 9 April, 2025 0

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Dr. Andrés Rodríguez - 8 April, 2025 0

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Dr. Omar Tupayachi - 8 April, 2025 0

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: FFR Guided PCI

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5...

Últimas Noticias

TAVR in Small Annuli: What Valve Should We Use?

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Noticias Institucionales

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

Watch our event on Evidence and Controversies of Renal Denervation in 2025

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

Accesos